Trial
NCT00265200
Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Louisville
Collaborators
James Graham Brown Cancer Center; Novartis Pharmaceuticals
Condition
Carcinoma, Non-Small Cell Lung
Intervention
zoledronic acid
Why stopped
funding discontinued by sponsor
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-03-05